The dopamine antagonist, Fupentixol did not affect the ghrelin-induced food intake. During the first half of the dark phase Fupentixol significantly increased the intake of standard chow, whereas a decrease in food intake was observed during the second part of the dark phase.
|Animal models||Male Sprague–Dawley rats|
|Formulation||sterile doubly distilled water|
|Body Surface Area (m2)||0.007||0.025||0.15||0.05||0.02||0.5|
|Animal A (mg/kg) = Animal B (mg/kg) multiplied by||Animal B Km|
|Animal A Km|
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
|Solubility||10 mM in DMSO|
Effect of cis-(Z)-flupentixol on DPPC membranes in the presence and absence of cholesterol.
Yonar D, et al. Chem Phys Lipids. 2016 Jun;198:61-71. PMID: 27282777.
The dopamine antagonist flupentixol does not alter ghrelin-induced food intake in rats.
Engster KM, et al. Neuropeptides. 2015 Oct;53:19-27. PMID: 26329764.
CA3 has potent inhibitory effects on YAP1/Tead transcriptional activity and primarily targets YAP1 high and therapy-resistant esophageal adenocarcinoma cells endowed with CSC properties.
YM 511 is a potent aromatase (CYP19) inhibitor.
|YM 298198 hydrochloride
YM 298198 hydrochloride is a highly potent, selective non-competitive mGlu 1 antagonist.
YM 022 is a highly potent, selective non-peptide CCK 2 antagonist.
YK 3-237 is a sIRT1 activator.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.